Male non-hormonal contraceptive implant shown to work for 24 months in trials
Stay up to date with notifications from The Independent
Notifications can be managed in browser preferences.
‘Major milestone’ for non-hormonal male contraceptive implant
- ADAM, a new implantable, non-hormonal male contraceptive, has proven effective for 24 months in clinical trials.
- The water-soluble hydrogel implant is placed in the sperm ducts, preventing sperm from mixing with semen.
- The implant is designed to be reversible and break down after a set time, restoring fertility.
- Trials showed no sperm in the semen of participants after 24 months, with no serious side effects reported.
- Contraline, the company behind ADAM, will begin phase two clinical trials in Australia later this year in what it described as a “major milestone”.